fff
Lv77
3700 积分
2023-02-17 加入
-
Ivonescimab versus pembrolizumab for PD-L1-positive non-small cell lung cancer (HARMONi-2): a randomised, double-blind, phase 3 study in China
1个月前
已采纳
-
Predefined-time output feedback consensus control for leader–follower second-order multiagent systems with actuator faults and input saturation based on event-triggered mechanism
1个月前
已采纳
-
Effectiveness of intermittent pneumatic compression in reduction of risk of deep vein thrombosis in patients who have had a stroke (CLOTS 3): a multicentre randomised controlled trial
1个月前
已采纳
-
Ivonescimab versus pembrolizumab for PD-L1-positive non-small cell lung cancer (HARMONi-2): a randomised, double-blind, phase 3 study in China
1个月前
已采纳
-
Ivonescimab versus pembrolizumab for PD-L1-positive non-small cell lung cancer (HARMONi-2): a randomised, double-blind, phase 3 study in China
1个月前
已驳回
-
The evolution of the Italian National Health Service
1个月前
已采纳
-
UNDP reports that 90% of people hold gender-based biases
1个月前
已采纳
-
Global, regional, and national prevalence of adult overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021
1个月前
已采纳
-
Global, regional, and national prevalence of adult overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021
1个月前
已采纳
-
OTOF-related gene therapy: a new way but a long road ahead
1个月前
已采纳